ArticleEuropean journal of applied physiology2026
Small airway dysfunction across alpha-1 antitrypsin deficiency genotypes with preserved spirometry.
Article in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAlpha-1 antitrypsin deficiency (AATD) is a genetic disorder that generally predisposes to pulmonary emphysema with or without chronic obstructive pulmonary disease (COPD). Despite the lack of spirometric obstruction, early Small Airways Dysfunction (SAD) may occur in AATD patients preceding lung damage.
methodsWe conducted a retrospective, single-center study on 60 AATD patients without airflow obstruction (FEV₁/FVC ≥ 0.70). SAD was defined as: reduced spirometric flows (≥2 of FEF25-75, FEF50, FEF75 <65% predicted) and/or IOS R5-R20 value greater than 0.07 kPa•s•L⁻¹. Correlation and agreement between spirometry and IOS were assessed, as well as associations with Modified Medical Research Council (mMRC) dyspnea scores.
resultsSAD was detected in 23% of patients by spirometry, 10% by IOS, and 13% by both methods. A slight agreement was found between spirometric and IOS criteria (κ = 0.22). Only IOS-defined SAD was significantly associated with dyspnea (mMRC ≥2; p = 0.05), and R5-R20 values correlated with mMRC scores (r = 0.38, p = 0.003). No association was observed between spirometry-defined SAD and symptoms.
conclusionsThese findings support IOS as a partially complementary tool for the early detection of peripheral airway impairment in AATD. Moreover, IOS but not spirometry criteria were related to breathlessness perception in AATD patients without airflow obstruction, with IOS proving to be a clinically more sensitive measure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.